As cerebral edema constitutes the main cause of death after IS [7, 12], this study assessed the therapeutic potential of an emerging strategy, employing hypoxia-primed OEC-CM, in mitigating the previously reported barrier-disruptive effects of TNF-α. Here, TNF is linked to brain edema.